Response, 'second look' status and survival in stage III-IV epithelial ovarian cancer treated with cis-dichlorodiammine platinum II (cis-platinum), adriamycin (ADR), and cytoxan (CTX)

C. E. Ehrlich, L. H. Einhorn, F. B. Stelman, L. M. Roth

Research output: Contribution to journalArticle

2 Scopus citations

Fingerprint Dive into the research topics of 'Response, 'second look' status and survival in stage III-IV epithelial ovarian cancer treated with cis-dichlorodiammine platinum II (cis-platinum), adriamycin (ADR), and cytoxan (CTX)'. Together they form a unique fingerprint.